Company / Depreciation & Amortization
Centessa Pharmaceuticals plc Depreciation & Amortization History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$921.0K
FY2025
5-year range
$34.0K / $942.0K
FY2021-FY2025
Trend
-2.2%
vs FY2024
Sector context
#132 of 177
Health Care
What the data says
Centessa Pharmaceuticals plc's depreciation & amortization of $921,000 is lower than 75% of companies in the Health Care sector (FY2025). Increased from $810,000 to $921,000 over the past 2 years.
Based on SEC 10-K filings.
$921,000 in FY2025 with a 3-year CAGR of +91.6%.
Increased from $810,000 to $921,000 over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +91.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 25% in Health CareTop 25% of 177This company $921.0K Sector average $204.7M
▼
-99.5% below sector average
Key checks
Key Insights
- 3-year CAGR of +91.6%, indicating consistent growth.
- In FY2025, depreciation & amortization decreased 2.2% year-over-year.
- Ranks #132 out of 177 companies in the Health Care sector.
- Peak depreciation & amortization was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.80 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $921.0K | -2.2% |
| FY2024 | $942.0K | +16.3% |
| FY2023 | $810.0K | +518.3% |
| FY2022 | $131.0K | +285.3% |
| FY2021 | $34.0K | - |
| FY2020 | $0 | -100.0% |
| FY2019 | $6.0K | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026